Endotoxin preconditioning protects neurones from in vitro ischemia: Role of endogenous IL-1β and TNF-α

Journal of Neuroimmunology

Volumn 173, Issue 1-2, 2006, Pages 108-116

  Lastres Becker, Isabel ^a   Cartmell, Tam ^b   Molina Holgado, Francisco ^c  

^a GOETHE UNIVERSITY   (Germany)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Endotoxin; IL 1 knock out mice; IL 6; Ischemia model; Neuroprotection; TNF

Indexed keywords

3 NITROPROPIONIC ACID; ENDOTOXIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL ACTIVATION; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; KNOCKOUT MOUSE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CEREBELLUM; CONVULSANTS; CULTURE MEDIA, CONDITIONED; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1; ISCHEMIA; MICE; MICE, KNOCKOUT; NEURONS; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; PROPIONIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644937686     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.12.006     Document Type: Article

References (44)

1. S.H. Ahmed, Y.Y. He, A. Nassief, J. Xu, X.M. Xu, C.Y. Hsu, and F.M. Faraci Effects of lipopolysaccharide priming on acute ischemic brain injury Stroke 31 2000 193 199
2. S.M. Allan, and N.J. Rothwell Cytokines and acute neurodegeneration Nat. Rev., Neurosci. 2 2001 734 744
3. S.M. Allan, and N.J. Rothwell Inflammation in central nervous system injury Philos. Trans. R. Soc. Lond., B Biol. Sci. 358 2003 1669 1677
4. S.M. Allan, P.J. Tyrrell, and N.J. Rothwell Interleukin-1 and neuronal injury Nat. Rev., Immunol. 5 2005 629 640
5. P.B. Andersson, V.H. Perry, and S. Gordon The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues Neuroscience 48 1992 169 186
6. S.W. Barger, D. Horster, K. Furukawa, Y. Goodman, J. Krieglstein, and M.P. Mattson Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation Proc. Natl. Acad. Sci. U. S. A. 92 1995 9328 9332
7. F.C. Barone, and G.Z. Feuerstein Inflammatory mediators and stroke: new opportunities for novel therapeutics J. Cereb. Blood Flow Metab. 19 1999 819 834
8. M.I. Behrens, J. Koh, L.M. Canzoniero, S.L. Sensi, C.A. Csernansky, and D.W. Choi 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons NeuroReport 6 1995 545 548
9. F. Belloc, P. Dumain, M.R. Boisseau, C. Jalloustre, J. Reiffers, P. Bernard, and F. Lacombe A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells Cytometry 17 1994 59 65
10. D. Boche, C. Cunningham, J. Gauldie, and V.H. Perry Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo J. Cereb. Blood Flow Metab. 23 2003 1174 1182
11. E. Brouillet, F. Conde, M.F. Beal, and P. Hantraye Replicating Huntington's disease phenotype in experimental animals Prog. Neurobiol. 59 1999 427 468
12. A.J. Bruce, W. Boling, M.S. Kindy, J. Peschon, P.J. Kraemer, M.K. Carpenter, F.W. Holtsberg, and M.P. Mattson Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors Nat. Med. 2 1996 788 794
13. A.J. Bruce-Keller, J.W. Geddes, P.E. Knapp, R.W. McFall, J.N. Keller, F.W. Holtsberg, S. Parthasarathy, S.M. Steiner, and M.P. Mattson Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD J. Neuroimmunol. 93 1999 53 71
14. M.A. Cambray-Deakin Cerebellar granule cells J. Cohen G. Wilkin Neural Cell Culture: A Practical Approach 1995 IRL Press Oxford, UK
15. G.R. Campbell, D. Magee, A. Kennedy, B.J. Rowlands, and M.I. Halliday An ELISA for measuring tumour necrosis factor alpha in rat plasma Eur. Cytokine Netw. 8 1997 97 102
16. L.M. Colletti, D.G. Remick, and D.A. Campbell LPS pretreatment protects from hepatic ischemia/reperfusion J. Surg. Res. 57 1994 337 343
17. U. Dirnagl, R.P. Simon, and J.M. Hallenbeck Ischemic tolerance and endogenous neuroprotection Trends Neurosci. 26 2003 248 254
18. G.P. Eising, L. Mao, G.W. Schmid-Schonbein, R.L. Engler, and J. Ross Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats Cardiovasc. Res. 31 1996 73 81
19. U. Heemann, A. Szabo, P. Hamar, V. Muller, O. Witzke, J. Lutz, and T. Philipp Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway Am. J. Pathol. 156 2000 287 293
20. R. Horai, M. Asano, K. Sudo, H. Kanuka, M. Suzuki, M. Nishihara, M. Takahashi, and Y. Iwakura Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion J. Exp. Med. 187 1998 1463 1475
21. N.K. Isaev, E.V. Stelmashook, K. Ruscher, N.A. Andreeva, and D.B. Zorov Menadione reduces rotenone-induced cell death in cerebellar granule neurons NeuroReport 15 2004 2227 22231
22. M. Jordan, I.G. Otterness, R. Ng, A. Gessner, M. Rollinghoff, and H.U. Beuscher Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist J. Immunol. 154 1995 4081 4090
23. K. Kariko, D. Weissman, and F.A. Welsh Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance J. Cereb. Blood Flow Metab. 24 2004 1288 12304
24. T. Kirino Ischemic tolerance J. Cereb. Blood Flow Metab. 22 2002 1283 1296
25. S.A. Loddick, A.V. Turnbull, and N.J. Rothwell Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat J. Cereb. Blood Flow Metab. 18 1998 176 179
26. K.D. MacCarthy, and J. de Vellis Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue J. Cell Biol. 85 1980 890 902
27. L. Marchetti, M. Klein, K. Schlett, K. Pfizenmaier, and U.L. Eisel Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway J. Biol. Chem. 279 2004 32869 32881
28. G. Martino How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders Lancet Neurol. 3 2004 372 378
29. M.P. Mattson, Y. Goodman, H. Luo, W. Fu, and K. Furukawa Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosinenitration J. Neurosci. Res. 49 1997 681 697
30. F. Molina-Holgado, R. Grencis, and N.J. Rothwell Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines Glia 33 2001 97 106
31. F. Molina-Holgado, E. Pinteaux, J.D. Moore, E. Molina-Holgado, C. Guaza, R.M. Gibson, and N.J. Rothwell Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia J. Neurosci. 23 2003 6470 6474
32. C. Nathan Points of control in inflammation Nature 420 2002 846 852
33. R. Obermaier, O. Drognitz, A. Grub, E. Von Dobschuetz, W. Schareck, U.T. Hopt, and S. Benz Endotoxin preconditioning in pancreatic ischemia/reperfusion injury Pancreas 27 2003 E51 E56
34. C. Olsen, A. Rustad, F. Fonnum, R.E. Paulsen, and B. Hassel 3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro Brain Res. 850 1999 144 149
35. H.L. Rosenzweig, N.S. Lessov, D.C. Henshall, M. Minami, R.P. Simon, and M.P. Stenzel-Poore Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice Stroke 35 2004 2576 2581
36. B. Safieh-Garabedian, S. Poole, A. Allchorne, J. Winter, and C.J. Woolf Contribution of interleukin-1 to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia Br. J. Pharmacol. 115 1995 1265 1275
37. A.H. Schapira Oxidative stress and mitochondrial dysfunction in neurodegeneration Curr. Opin. Neurol. 9 1996 260 264
38. B. Schöbitz, D.A.M. Voorhuis, and E.R. De Kloet Localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain Neurosci. Lett. 136 1992 189 192
39. K. Tasaki, C.A. Ruetzler, T. Ohtsuki, D. Martin, H. Nawashiro, and J.M. Hallenbeck Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats Brain Res. 748 1997 267 270
40. H. Tilg, E. Trehu, M.B. Atkins, C.A. Dinarello, and J.W. Mier Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 Blood 83 1994 113 118
41. H. Tilg, C.A. Dinarello, and J.W. Mier IL-6 and APPs: anti-inflammatory and immunosuppressive mediators Immunol. Today 18 1997 428 432
42. G. Wang, H. Deng, C. Maier, G. Sun, and M. Yenari Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke Neuroscience 114 2002 1081 1090
43. D. Watanabe, R. Yoshimura, M. Khalil, K. Yoshida, T. Kishimoto, T. Taga, and H. Kiyama Characteristic localization of gp 130 (the signal transducing receptor component used in common for IL-6/IL-11/CNTF/OSM) in the rat brain Eur. J. Neurosci. 8 1996 1630-1640
44. C. Zimmermann, I. Ginis, K. Furuya, D. Klimanis, C. Ruetzler, M. Spatz, and J.M. Hallenbeck Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma Brain Res. 895 2001 59 65